We are developing the new standard of care for the targeted temperature management of patients after
Location: Italy, Emilia-Romagna, Modena
Employees: 1-10
Phone: +39 331 263 1016
Total raised: $1.47M
Founded date: 2013
Funding Rounds 2
| Date | Series | Amount | Investors |
| 09.11.2021 | - | $753.64K | - |
| 23.12.2015 | - | $715.64K | - |
Mentions in press and media 3
| Date | Title | Description |
| 26.09.2023 | Is Targeted Temperature Management the Future of Brain Injury Treatment? | Key Takeaways: Neuron Guard has developed the standard of care for Targeted Temperature Management (TTM) therapy. The device can be used in any circumstance and allows the user to fully manage the temperature of the patient, either warming ... |
| 23.12.2015 | Neuron Guard Raises €656K in Funding | Neuron Guard, a Modena, Italy-based developer of a medical device for patients with Acute Brain Damage (ABD), raised €656k in funding. Backers included A11 Venture and other private investors. The company, which has also raised €250k intern... |
| 02.12.2014 | M31 Acquires SeedLab | Padua, Italy-based Tech incubator M31 acquired SeedLab, a Milan, Italy science-based startup acceleration program. The amount of the transaction was not disclosed. Led by Matteo Faggin, Principal, SeedLab was created as an acceleration prog... |